Trial Details
COMPLETEDBasic Information
| Clinical ID | c1388 |
|---|---|
| Identifier | NCT03558152 |
| Trial Title | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: UTTR1147A|DRUG: UTTR1147A Placebo|DRUG: Vedolizumab|DRUG: Vedolizumab Placebo |
Participant Information
| Sponsor | Genentech, Inc. |
|---|---|
| City | Greenville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-10-26 |
|---|---|
| Primary Completion Date | 2021-12-15 |
| Completion Date | 2021-12-15 |